Showing results (321-330 of 422) with videos related to
Sort By:
Pageof 43
BJU International|June 26, 2003
Stage I seminoma of the testis: a bi-institutional retrospective analysis of patients treated with radiation therapy onlyR Santoni, F Barbera, F Bertoni, et al.Leukemia & Lymphoma|October 8, 1999
Primary mediastinal large B-cell lymphoma (PMLCL): the need for prospective controlled clinical trialsS Bieri, E Roggero, E Zucca, et al.European Urology|January 1, 1992
The prognostic significance of DNA ploidy pattern in transitional cell cancer of the renal pelvis and ureter: continuing follow-upF Corrado, D Mannini, C Ferri, et al.Journal of Chemotherapy (Florence, Italy)|February 1, 1996
Intra-arterial versus intravenous cisplatinum (in addition to systemic Adriamycin and high dose methotrexate) in the neoadjuvant treatment of osteosarcoma of the extremities. results of a randomized studyG Bacci, P Ruggieri, P Picci, et al.International Journal of Oncology|May 5, 2011
Value of immunohistochemical detection of noncollagenous proteins of bone for the diagnosis of bone tumoursM Serra, K Scotlandi, M Sollazzo, et al.Critical Reviews in Oncology/Hematology|October 20, 2022
A systematic review of contemporary phase I trials in patients with lymphomaG Griguolo, M F Zorzi, M C Pirosa, et al.Leukemia & Lymphoma|December 28, 1999
Primary mediastinal large B-cell lymphoma: the need for prospective controlled clinical trialsS Bieri, E Roggero, E Zucca, et al.Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|April 1, 1988
Neoadjuvant chemotherapy for osteosarcoma of the extremities. Good response of the primary tumor after preoperative chemotherapy with high-dose methotrexate followed by cisplatinum and adriamycin. Preliminary resultsG Bacci, M Avella, A Brach Del Prevert, et al.Archives of Orthopaedic and Traumatic Surgery. Archiv Fur Orthopadische Und Unfall-Chirurgie|January 1, 1987
Complications of pelvic resectionsR Capanna, J R van Horn, N Guernelli, et al.Cancer|June 22, 1999
Synovial sarcoma: identification of low and high risk groupsP Bergh, J M Meis-Kindblom, F Gherlinzoni, et al.Pageof 43